Nexmed sells US rights to topical ED treatment to Warner Chilcott
This article was originally published in Scrip
Executive Summary
Nexmed has agreed to sell the US rights to Vitaros, a topical alprostadil cream for the treatment of erectile dysfunction, to its partnerWarner Chilcott.